| Amy Frierson, | |
|
3443 Dickerson Pike Ste 680, Nashville, TN 37207-2537 | |
| (615) 865-3322 | |
| (615) 467-6692 |
| Full Name | Amy Frierson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 3443 Dickerson Pike Ste 680, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902455652 | NPI | - | NPPES |
| Q054315 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 24704 (Tennessee) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 24704 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Middle Tennessee Pulmonary Associates Llc | 8628090958 | 28 |
News Archive
Researchers on Mayo Clinic's Florida campus have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent.
No beneficial effects were found on cognitive function, bone mineral density or plasma lipids when postmenopausal women age 60 years or older took soy protein supplements with isoflavones for one year
Analysis of climatic conditions and the propensity for travel has identified many countries across Africa and Asia-Pacific that are at high risk of Zika virus transmission.
Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients' tumors do not respond to these drugs.
› Verified 6 days ago
| Entity Name | Middle Tennessee Pulmonary Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215008032 PECOS PAC ID: 8628090958 Enrollment ID: O20101014000119 |
News Archive
Researchers on Mayo Clinic's Florida campus have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent.
No beneficial effects were found on cognitive function, bone mineral density or plasma lipids when postmenopausal women age 60 years or older took soy protein supplements with isoflavones for one year
Analysis of climatic conditions and the propensity for travel has identified many countries across Africa and Asia-Pacific that are at high risk of Zika virus transmission.
Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients' tumors do not respond to these drugs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Frierson, 3443 Dickerson Pike Ste 680, Nashville, TN 37207-2537 Ph: (615) 865-3322 | Amy Frierson, 3443 Dickerson Pike Ste 680, Nashville, TN 37207-2537 Ph: (615) 865-3322 |
News Archive
Researchers on Mayo Clinic's Florida campus have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent.
No beneficial effects were found on cognitive function, bone mineral density or plasma lipids when postmenopausal women age 60 years or older took soy protein supplements with isoflavones for one year
Analysis of climatic conditions and the propensity for travel has identified many countries across Africa and Asia-Pacific that are at high risk of Zika virus transmission.
Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients' tumors do not respond to these drugs.
› Verified 6 days ago